Signs a Community Health Screening Program Is Actually Scaling

Most community health screening programs do not fail at the idea stage. They fail at the transition between a funded pilot and a system that keeps running once the launch grant closes. For anyone assessing program maturity, the hard part is reading the difference early, while the numbers still look encouraging. A pilot that screened 4,000 people in eight villages and a program on a genuine path to district coverage can produce nearly identical first-year dashboards. The signals that separate them are structural, not cosmetic, and they appear well before a program either consolidates or quietly winds down. This report sets out what scaling community health programs actually look like from the inside, and which indicators distinguish durable expansion from impressive but stalling activity.

By 2024, more than 1 million community health workers had been deployed across Africa, roughly 50 percent of the African Union target of 2 million by 2030, yet community health worker density remains near 7 per 10,000 people against an estimated need of 11.2 to 59.5 per 10,000 for universal health coverage. Source: synthesis of African Union deployment reporting and Boniol et al., WHO health workforce estimates, 2022 to 2024.

What scaling community health programs really means

Scaling is not the same as growing. A program can add screening sites, scans, and staff every quarter and still be a pilot, because growth funded entirely by a single donor with no path into government budgets or routine systems is expansion without permanence. The distinction matters most to grant-making bodies, because the question is rarely whether a program can do more of what it already does. The question is whether the additional activity will survive the end of the grant that paid for it.

The WHO and ExpandNet framework, set out by Ruth Simmons and colleagues in Nine Steps for Developing a Scaling-Up Strategy (WHO, 2010), draws a useful line between two processes that often get conflated. Horizontal scaling is replication, the same model copied into new geographies. Vertical scaling, or institutionalization, is the harder work of embedding a model into policy, financing, and the routine operations of a health system. Programs that report only horizontal numbers, more districts, more workers, more scans, while showing no vertical progress, are the ones most likely to stall. The strongest early signal of real scale is movement on both axes at once.

This is also where the well-documented problem of pilotitis lives. Reviews of mHealth deployments in low- and middle-income countries consistently find that promising pilots collapse when external funding ends, because they were conceived outside government priorities, never integrated with existing health information systems, and never built a financing model beyond the launch grant. Scaling mHealth deployments successfully depends less on the technology performing and more on whether the surrounding system absorbs it.

A comparison: stalling pilot versus scaling program

The clearest way to assess maturity is to compare the same dimensions across two trajectories that can look alike on a surface dashboard.

Dimension	Stalling pilot	Scaling program
Funding base	Single donor, project-coded budget	Multiple sources, with a line item in district or national budgets
Government role	Informed, occasionally consulted	Co-owner, with named accountability in the health office
Data systems	Parallel app or spreadsheet	Integrated with the national health information system
Workforce	Project-paid, high attrition at grant end	Salaried or formally incentivized, retention tracked
Geography	Expands only where the funder pays	Replication driven by district demand
Evidence use	Reports activity counts	Reports outcomes and cost per outcome
Failure mode	Quiet shutdown after closeout	Absorbed into routine service delivery

The right-hand column is not aspirational language. Each item is observable in the first 12 to 18 months, which is why these dimensions are more predictive than headline scan totals.

Early growth indicators worth tracking

When assessing whether a screening program is on a scaling path, a handful of program growth indicators carry more weight than volume metrics:

• Co-financing ratio: the share of recurring costs covered by sources other than the original grant, and whether that share is rising.
• Workforce retention: attrition among community health workers, since volunteer-based models show markedly higher dropout than salaried or incentivized ones.
• Data integration depth: whether screening records flow into the routine health information system or sit in a separate database that no one inherits.
• Demand-led replication: new sites requested by district health offices rather than offered by the funder.
• Referral completion: the proportion of flagged cases that reach and complete onward care, which tests whether screening connects to the rest of the system.
• Unit economics: a stable or falling cost per person screened and per case identified as volume grows.

A program improving on most of these is maturing. A program with rising scan counts but flat co-financing and worsening retention is, in practice, a pilot running on momentum.

Industry Applications

Grant-making and portfolio review

For funders, these signals translate directly into due diligence. A sustainability assessment that looks only at reach and satisfaction will reward activity, not durability. The more useful review weights institutional signals, budget integration, government co-ownership, and data interoperability, alongside reach. The Monrovia Call to Action in March 2023 made the same point at policy level, urging harmonized funding and country-led ownership precisely because fragmented, donor-by-donor support produces programs that cannot survive any single funder leaving.

Expanding rural screening operations

In rural settings the constraints are physical as much as financial. Reviews of mHealth in low-resource settings repeatedly name unreliable electricity, weak connectivity, and limited devices as the barriers that quietly cap scale. Expanding rural screening that depends on constant connectivity tends to stall outside the pilot zone, while models designed for offline-first operation and intermittent sync are far more replicable. The technical design choice is, in effect, a scaling decision made years before the scaling question is asked.

Research and evaluation partnerships

For academic and public health institutions, scaling programs are valuable study sites because they generate longitudinal, system-level data rather than a single cross-section. A program integrated into routine systems produces the denominators, follow-up, and cost data that publishable evaluation requires. The integration that signals sustainability is the same integration that makes rigorous research possible.

Current research and evidence

The evidence base is consistent on why programs stall. Syntheses of mHealth adaptability, scalability, and sustainability in low- and middle-income countries identify a recurring cluster of failure points: donor dependence without a sustainable financing model, weak governance and limited government ownership, poor interoperability with existing health information systems, and insufficient community involvement. None of these are technology faults. They are system-fit faults.

On workforce, the World Health Organization's health workforce analyses, drawing on the work of researchers including Mathieu Boniol, place community health worker density across much of Africa near 7 per 10,000 people, well short of the 11.2 to 59.5 per 10,000 associated with universal health coverage. The African Union's progress toward 2 million community health workers by 2030, roughly half met by 2024, shows that deployment can scale even where retention and financing remain fragile. That gap between deployment and durability is exactly what maturity assessment needs to detect. Retention studies, including five-year cohort work on volunteer community health workers in rural Uganda, confirm that attrition is highest where incentives are weakest, making retention one of the more honest leading indicators of whether scale will hold.

WHO's World Health Statistics 2024 adds the macro caution: progress toward most health-related Sustainable Development Goal targets is off track, which means scarce funding will increasingly flow to programs that can demonstrate not just reach but staying power.

The future of scaling community health programs

The direction of travel favors programs that can prove institutional fit, not just field activity. Three shifts are likely to define the next several years. First, co-financing will move from a nice-to-have to a gating criterion, with funders asking on day one how recurring costs survive closeout. Second, interoperability standards will harden, so that screening data which cannot enter the national health information system will be treated as a liability rather than a feature. Third, evaluation will shift from activity reporting toward outcome and cost-per-outcome reporting, rewarding programs that already track unit economics. For grant-making bodies, the practical implication is that maturity assessment should be designed to read these structural signals early, while a program can still adjust, rather than confirming the diagnosis at closeout when nothing can be changed.

Frequently asked questions

How early can you tell whether a screening program will scale or stall? Usually within the first 12 to 18 months. The predictive signals are structural, co-financing trajectory, government co-ownership, data integration, and workforce retention, and these appear well before reach metrics reveal anything. Volume alone is not diagnostic, because pilots and scaling programs produce similar early reach numbers.

Why do so many community health pilots fail to scale? The dominant reasons are not technical. Research on mHealth in low- and middle-income countries points to donor dependence without a sustainable financing model, weak government ownership, poor interoperability with existing health information systems, and limited community involvement. Programs conceived outside government priorities rarely find a budget to continue once the launch grant ends.

What is the single most useful sustainability signal for a funder? The co-financing ratio and its direction over time. A program where a growing share of recurring costs is covered by government budgets or diversified sources is institutionalizing. One funded entirely by a single grant, however large its reach, has not yet demonstrated durability.

Does workforce retention really indicate scalability? Yes. Attrition is among the most honest leading indicators because it reflects whether the program has solved financing and working conditions, not just activity. Cohort studies show volunteer-based models lose workers far faster than salaried or incentivized ones, and a program shedding workers as a grant winds down is unlikely to sustain coverage.

Circadify is working in this space, building contactless screening tools and field evidence designed to integrate with routine systems rather than sit beside them, which is the integration that distinguishes durable scale from a stalling pilot. Grant-making bodies and research partners exploring sustainability assessment can review the underlying research and collaboration options at circadify.com/blog.